CSIMarket
 
Swk Holdings Corporation  (SWKH)
Other Ticker:  
 
    Sector  Financial    Industry Professional Services
   Industry Professional Services
   Sector  Financial
 
Price: $17.4500 $1.35 8.385%
Day's High: $17.49 Week Perf: 7.25 %
Day's Low: $ 15.92 30 Day Perf: 4.49 %
Volume (M): 214 52 Wk High: $ 18.76
Volume (M$): $ 3,736 52 Wk Avg: $16.70
Open: $15.92 52 Wk Low: $15.26



 Market Capitalization (Millions $) 220
 Shares Outstanding (Millions) 13
 Employees 3
 Revenues (TTM) (Millions $) 38
 Net Income (TTM) (Millions $) 16
 Cash Flow (TTM) (Millions $) 12
 Capital Exp. (TTM) (Millions $) 0

Swk Holdings Corporation

SWK Holdings Corporation incorporated in July 1996 in California and reincorporated in Delaware in September 1999. In July 2012, we commenced our corporate strategy of building a specialty finance and asset management business. Our strategy is to be a leading healthcare capital provider by offering sophisticated, customized financing solutions to a broad range of life science companies, institutions and inventors. Our focus is on monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. We are deploying our assets to earn interest, fees, and other income pursuant to this strategy, and we continue to identify and review financing and similar opportunities on an ongoing basis. In addition, through our wholly-owned subsidiary, SWK Advisors LLC, we provide non-discretionary investment advisory services to institutional clients in separately managed accounts to similarly invest in life science finance. SWK Advisors LLC is registered as an investment advisor with the Texas State Securities Board. We intend to fund transactions through our own working capital, as well as by building our asset management business by raising additional third party capital to be invested alongside our capital.

We fill a niche that we believe is underserved in the sub-$50 million transaction size. Since many of our competitors that provide longer term, royalty-related financing options have much greater financial resources than us, they tend not to focus on transaction sizes below $50 million as it is generally inefficient for them to do so. In addition, we do not believe that a sufficient number of other companies offer similar types of long-term financing options to fill the demand of the sub-$50 million market.

We evaluate and invest in a broad range of healthcare related companies and products with innovative intellectual property, including the biotechnology, medical device, medical diagnostics and related tools, animal health and pharmaceutical industries (together “life science”) and to tailor our financial solutions to the needs of our business partners. Our business partners are primarily engaged in selling products that directly or indirectly cure diseases and/or improve people’s or animals’ wellness, or they receive royalties paid on the sales of such products. For example, our biotechnology and pharmaceutical business partners manufacture medication that directly treat disease states, whereas our life science tools partners sell a wide variety of research instrumentation to help other companies conduct research into disease states.

The majority of our transactions are structured similarly to factoring transactions whereby we provide capital in exchange for an interest in an existing revenue stream. We do not anticipate providing capital in situations prior to the commercialization of a product. The existing revenue stream can take several forms, but is most commonly either a royalty derived from the sales of a life science product (1) from the marketing efforts of a third party, such as a royalty paid to an inventor on the sales of a medicine, or (2) from the marketing efforts of a partner company, such as a medical device company that directly sells its own products. Our structured debt investments may include warrants or other features, giving us the potential to realize enhanced returns on a portion of our portfolio. Capital that we provide directly to our partners is generally used for growth and general working capital purposes, as well as for acquisitions or recapitalizations in select cases. We generally fund the full amount of transactions up to $20 million through our working capital.


Our investment advisory agreements are currently non-discretionary and each client determines individually if it wants to participate in a transaction. Each account receives its pro rata allocation for a transaction based on which clients opt into a transaction, and each account receives its pro rata allocation of income produced by a transaction in which it participates. Clients pay us management and incentive fees according to a written investment advisory agreement, and we negotiate fees based on each client’s needs and the complexity of the client’s requirements. Fees paid by clients may differ depending upon the terms negotiated with each client and are paid directly by the client upon receipt of an invoice from us. We may seek to raise discretionary capital from similar investors in the future.



   Company Address: 5956 Sherry Lane Dallas 75225 TX
   Company Phone Number: 687-7250   Stock Exchange / Ticker: NASDAQ SWKH
   SWKH is expected to report next financial results on March 30, 2024.


Customers Net Income grew by SWKH's Customers Net Profit Margin grew to

558.23 %

10.7 %

• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
BLK   -2.74%    
BX        0.32% 
CG   -4.8%    
KKR   -0.71%    
SNEX   -2.22%    
VOYA        1.98% 
• View Complete Report
   



Swk Holdings Corporation

SWKH: Transforming Contractions into Opportunities! A Closer Look at SWK Holdings Corporation's Earnings Per Share Contraction

Investors Concerned as Swk Holdings Corporation Reports Decline in Earnings and Revenue
In the July to September 30, 2023 financial time-frame, Swk Holdings Corporation experienced a downturn in its earnings and revenue. The company's earnings per share dropped by -29.41% to $0.36 per share in comparison to $0.51 per share the previous year. However, there was a positive trend in earnings per share from the prior reporting season, with an increase of 16.13% from $0.31 per share.
Unfortunately, the decline in earnings was parallel to a significant reduction in revenue by -34.171%, amounting to $8.96 million from $13.61 million in the corresponding period the previous year. Additionally, there was a sequential decrease in revenue by -5.633% from $9.50 million. This decline in revenue indicates a challenging period for Swk Holdings Corporation.

Swk Holdings Corporation

Swk Holdings Corporation Surges with 675% EPS Increase in Recent Fiscal Period

Swk Holdings Corporation, a leading player in the financial services industry, recently released its second-quarter earnings report for 2023. The company has shown significant growth in key financial indicators, illustrating its strong performance and positive market outlook.
One of the noteworthy achievements for Swk Holdings Corporation in the second quarter was the soaring year-on-year earnings per share, which increased by an impressive 675% to $0.31 per share. This substantial growth is attributed to the company's continuous focus on increasing revenue, which saw a commendable rise of 36.805% to $9.50 million compared to the previous year.

Swk Holdings Corporation

Swk Holdings Corporation Overcomes Challenging Business Environment with Impressive Q1 Earnings, but Faces Revenue Decline of -15.452%

Swk Holdings Corporation Soars During Q1 Earnings Season
Swk Holdings Corporation has reported impressive results during the first quarter of 2023 earnings season. The company's profit per share rose to $0.36, representing a significant increase of 33.33% when compared to $0.27 per share recorded in the same reporting period last year. The income per share also surged by 63.83% from $0.22 per share from the previous reporting season, showcasing the growth and potential of the company.
Despite these impressive results, Swk Holdings Corporation recorded a substantial decline in revenue during the first quarter of 2023 earnings season. The company's revenue receded by -15.452% to $9.41 million from $11.13 million in the same reporting season a year ago. Sequentially, revenue also decreased by -3.94% from $9.80 million. However, the company reported earnings of $4.635 million, a 33.27% increase from net earnings of $3.478 million reported in the first quarter of 2023 earnings season a year ago.






 

Swk Holdings's Segments
 
 
• View Complete Report




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com